SCHEMBL23988778

SCHEMBL23988778

COc1cc2c(-c3cnn4cc(C)cnc34)ccnc2cc1O

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ACVR1 Q04771 20/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23988699 0.88 ACVR1 (0.69) ACVR1
SCHEMBL23988880 0.82 ACVR1 (0.58) ACVR1
SCHEMBL23988847 0.82 ACVR1 (0.60) ACVR1
SCHEMBL23988861 0.82 BMP4 (0.64) ACVR1
SCHEMBL23988873 0.80 ACVR1 (0.62) ACVR1
SCHEMBL23988890 0.78 ACVR1 (0.61) ACVR1
SCHEMBL23988731 0.78 ACVR1 (0.55) ACVR1
SCHEMBL23988856 0.77 BMP4 (0.55) ACVR1
SCHEMBL23988791 0.77 BMP4 (0.67) ACVR1
SCHEMBL23988744 0.76 ACVR1 (0.60) ACVR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222875-A1 METHODS OF USING ALK2 INHIBITORS KEROS THERAPEUTICS, INC. (US) 2021-11-04 — — WO disclosed
Send feedback